Company Profiles

driven by the PitchBook Platform

Orphazyme

Description

Operator of a biotech company created to develop treatments for protein misfolding diseases, including lysosomal storage diseases with neurological pathologies, and neuro-degenerative disorders. The company's biotech facilities develops therapeutics for the treatment of lysosomal storage diseases, a group of rare genetic disorders that result from deficiencies of lysosomal enzymes or other lysosomal components, enabling patients to survive premature death.

2009

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$15M

Latest Deal Amount

$66M

Total Amount Raised

Description

Operator of a biotech company created to develop treatments for protein misfolding diseases, including lysosomal storage diseases with neurological pathologies, and neuro-degenerative disorders. The company's biotech facilities develops therapeutics for the treatment of lysosomal storage diseases, a group of rare genetic disorders that result from deficiencies of lysosomal enzymes or other lysosomal components, enabling patients to survive premature death.

Website:

www.orphazyme.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Therapeutic Devices
Pharmaceuticals

Primary Office

Ole Maaløes Vej 3 2200 CopenhagenDenmark +45 7070 2980
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Orphazyme's full profile, request a free trial.

Orphazyme Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Orphazyme Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Aescap VentureVenture CapitalMinority000 0000000 0000
ALS Investment FundVenture CapitalMinority000 0000000 0000
IdInvest PartnersPE/BuyoutMinority000 0000000 0000
Kurma PartnersVenture CapitalMinority000 0000000 0000
Life Sciences PartnersVenture CapitalMinority000 0000000 0000
Aescap Venture Venture Capital
ALS Investment Fund Venture Capital
IdInvest Partners PE/Buyout
Kurma Partners Venture Capital
Life Sciences Partners Venture Capital

Orphazyme Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Anders Mørkeberg Hinsby Ph.DCo-Founder & Chief Executive Officer
Anders VadsholtChief Financial Officer
Thomas Kirkegaard Jensen Ph.DCo-Founder & Chief Scientific Officer
Soren Neve Ph.DDirector of pharmacology
Martin KornumCo-Founder, Director of IPR and Board Member
Anders Mørkeberg Hinsby Ph.D Co-Founder & Chief Executive Officer
Anders Vadsholt Chief Financial Officer
Thomas Kirkegaard Jensen Ph.D Co-Founder & Chief Scientific Officer
Soren Neve Ph.D Director of pharmacology
Martin Kornum Co-Founder, Director of IPR and Board Member

Orphazyme Board Members (11)

NameRepresentingRoleSinceContact
Info
Bo Jesper Hansen Ph.DSelfBoard Member000 0000
Georges Gemayel Ph.DSelfChairman000 0000
Kim Dueholm Ph.DNovoPartner000 0000
Martijn KleijwegtLife Sciences PartnersFounder & Managing Partner000 0000
Martin Bonde Ph.DSelfBoard Member000 0000
Bo Jesper Hansen Ph.D Board Member Self
Georges Gemayel Ph.D Chairman Self
Kim Dueholm Ph.D Partner Novo
Martijn Kleijwegt Founder & Managing Partner Life Sciences Partners
Martin Bonde Ph.D Board Member Self
Request full access to PitchBook